Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

03/02/2022 04:30

Feb 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             57.71               57.08            79.20    
                 (+1.1 pct)          (-18.7 pct)      (+5.6 pct)  
  Operating         13.89               14.95            18.80    
                 (-7.1 pct)          (-33.4 pct)      (+5.7 pct)  
  Recurring         14.32               15.35            19.20    
                 (-6.7 pct)          (-32.8 pct)      (+5.4 pct)  
  Net               10.25               10.93            14.00    
                 (-6.3 pct)          (-29.7 pct)      (+4.4 pct)  
  EPS            269.41 yen          282.69 yen       370.19 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T